Search Results 1011-1020 of 18167 for Tuberculosis

  1. Urinary tract infection (UTI) - Doctors and departments - Mayo Clinic

    Learn about symptoms of urinary tract infections. Find out what causes UTIs, how infections are treated and ways to prevent repeat UTIs.

  2. Urinary tract infection (UTI) - Symptoms and causes - Mayo Clinic

    Learn about symptoms of urinary tract infections. Find out what causes UTIs, how infections are treated and ways to prevent repeat UTIs.

  3. Fluticasone (inhalation route) - Side effects & dosage - Mayo Clinic

    Tuberculosis, active or history of—Inhaled fluticasone can reduce the body's ability to fight off these infections. Infection or; Stress or; Surgery or; Trauma ...

  4. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

    No active tuberculosis. No live vaccines within 28 days prior to registration. No history of allergic reaction to the study agent, compounds of similar ...

  5. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

    - Active tuberculosis - Other uncontrolled, significant intercurrent or recent illness including, but not limited to, the following conditions ...

  6. Infectious diseases - Diagnosis & treatment - Mayo Clinic

    Viruses, bacteria, fungi and parasites all can cause infections. Find out more about how to prevent and treat these conditions.

  7. Bronchoscopic Release Of Air Trapped In Hyperinflated Emphysematous Lung - Mayo Clinic

    Subject has known unresolved lower respiratory tract infection (e.g., pneumonia, mycobacterium avium-intracellulare infection (MAI), fungus, tuberculosis).

  8. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors - Mayo Clinic

    ... tuberculosis; Severe infection within 4 weeks prior to initiation of study treatment; Treatment with therapeutic oral or IV antibiotics within 2 weeks prior ...

  9. A Study to Evaluate LY3484356 Alone or Combined with Anticancer Therapies to Treat Patients with Breast or Endometrial Cancer - Mayo Clinic

    Participation eligibility · Participants must not have certain infections such as hepatitis or tuberculosis or HIV that are not well controlled. · Participants ...

  10. Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy - Mayo Clinic

    A clinically significant infectious illness (e.g., cellulitis, abscess, pneumonia, septicemia, tuberculosis) within 3 months prior to randomization, or PML ...